Apontis Pharma AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 55.73 million compared to EUR 51.18 million a year ago. Net income was EUR 2.69 million compared to net loss of EUR 0.745236 million a year ago.